Reference information
Historical FDA context for magnetic-field devices.
This page keeps the requested historical timeline. Each milestone relates to a particular device category and labelled use.
In a 2022 IEEE lab study, researchers observed changes that they interpreted as a possible increase in the negative surface charge of red blood cells.
Read the study (IEEE, 2022)- 1979
Bone-growth stimulation for non-union fractures
Historical FDA authorisation for a specific electromagnetic bone-growth device category and a defined fracture indication.
Source: Cadossi R, Massari L, Racine-Avila J, Aaron RK. Pulsed Electromagnetic Field Stimulation of Bone Healing and Joint Preservation. JAAOS Global Research & Reviews. 2020.
Open source - 1987
Postoperative pain and oedema device use
A historical, device- and indication-specific regulatory milestone described in the PEMF literature.
Source: Waldorff EI, Zhang N, Ryaby JT. Pulsed Electromagnetic Field Applications: A Corporate Perspective. Journal of Orthopaedic Translation. 2017.
Open source - 1998
Muscle stimulation and urinary incontinence devices
A historical FDA milestone for particular electromagnetic device uses. It is not a general wellness-device approval.
Source: Waldorff EI, Zhang N, Ryaby JT. Journal of Orthopaedic Translation. 2017.
Open source - 2004
Cervical spine fusion support
FDA authorisation for the named Cervical-Stim device in a defined adjunct spinal-fusion setting.
Source: FDA PMA P030034, Cervical-Stim Model 505L Cervical Fusion System.
Open source - 2008
Transcranial magnetic stimulation
An FDA milestone for a separate transcranial magnetic stimulation device category and labelled adult indication.
Source: Cohen SL, Bikson M, Badran BW, George MS. Brain Stimulation. 2022.
Open source - 2011
Tumour Treating Fields
An FDA milestone for a separate Tumour Treating Fields device category and its specific labelled use.
Source: Rominiyi O, Vanderlinden A, Clenton SJ, et al. British Journal of Cancer. 2021.
Open source